Health Care Equipment

Venus Concept

Venus Concept released FY2025 9 Months earnings on November 13 Pre-Market EST, actual revenue USD 43.11 M, actual EPS USD -37.6135

Venus Concept released FY2025 Q3 earnings on November 13 Pre-Market EST, actual revenue USD 13.78 M (forecast USD 14.48 M), actual EPS USD -12.14 (forecast USD -3.61)

Venus Concept to Release FY2025 Q3 Earnings on November 13, Pre-Market EST; Forecast Revenue USD 14.48M, EPS USD -3.61

Venus Concept released FY2025 Q2 earnings on August 14 After-Market EST, actual revenue USD 15.69 M (forecast USD 14.01 M), actual EPS USD -8.0335 (forecast USD -9.72)

Venus Concept released FY2025 Semi-Annual earnings on August 14 After-Market EST, actual revenue USD 29.34 M, actual EPS USD -22.18

Venus Concept to Release FY2025 Q2 Earnings on August 14 After-Market EST, Forecast Revenue USD 14.01 M, EPS USD -9.72

Venus Concept Inc. to Release Q2 2025 Financial Results

Venus Concept Inc. Elected Class II Directors and Approved Auditor

Venus Concept Completes Up To $3.45 Million Registered Direct Offering

Venus Concept Inc Signs Unit Purchase Agreement

Venus Concept Inc. Issuing Shares and Warrants

Venus Concept Inc Sells Venus Hair Business for $20 Million

Venus Concept released FY2025 Q1 earnings on May 15 Pre-Market (EST), actual revenue USD 13.64 M (forecast USD 13.98 M), actual EPS USD -17.44 (forecast USD -14.62)

Venus Concept Inc Expected to Report Quarterly Loss of $14.08 per Share in 2025

Venus Concept to release FY2025 Q1 earnings on May 15 Pre-Market EST, forecast revenue USD 13.98 M, EPS USD -14.62

Venus Concept Inc. Extends Bridge Loan Maturity Date

Venus Concept Converts $11 Million Subordinated Convertible Bonds into 379,311 Preferred Shares, Debt Reduced by 54%

Venus Concept released FY2024 annual earnings on March 31 Pre-Market (EST), actual revenue 64.83 M USD (forecast 66.05 M USD), actual EPS -71.21 USD (forecast -75.1849 USD)

Venus Concept released FY2024 Q4 earnings on March 31 Pre-Market (EST), actual revenue 15.77 M USD (forecast 16.99 M USD), actual EPS -11.2531 USD (forecast -10.01 USD)

Venus Concept Inc expects a loss of $10.01 per share and a 6.2% decline in quarterly revenue

Myseum

Onfolio

Psyence Biomedical

Meiwu Tech

WeShop

Julong

Mega Fortune

Dare Bioscience

Greenland Energy

Tradr 2X Long NVTS Daily ETF

Delcath

Abbott Laboratories

Intuitive Surgical

Stryker

Boston Scientific

IDEXX Labs

Edwards Lifesciences

Resmed

DexCom

Steris

Style Score

Growth Score

Revenue YoY

Net Profit YoY

Value Score

P/B Ratio

Dividend Ratio

Size Score

Market Cap Score

Market Cap

Revenue Score

Revenue

Multi Score

Profit Score

Profit Margin

Gross Margin

Total Assets YoY

Net Assets YoY

Cash Score

Cash Flow Margin

OCF YoY

Operating Score

Turnover

Debt Score

Gearing Ratio

Please note that a "Suspected value trap" is a stock that appears The stock looks financially sound and severely undervalued, but behind the low valuation is a long-term decline in business capacity or a serious financial crisis, or even the risk of bankruptcy in the short term.

Suspected value trap

Venus Concept(VERO.US)

Venus Concept Stock Performance Chart